Results 151 to 160 of about 1,443,018 (217)

Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]

J Bras Nefrol
Mathew GG.
europepmc   +1 more source

Hematological indices derived from complete blood count and unfavorable outcomes in patients under-going peritoneal dialysis. [PDF]

J Bras Nefrol
Alves TVG, Giarola LTP, Oliveira Júnior WV, Rios DRA.   +3 more
europepmc   +1 more source

Chemotherapy-induced cardiotoxicity in cancer patients: an observational study at an Oncology reference hospital from southeastern Brazil. [PDF]

Rev Lat Am Enfermagem
Neumann K, Nunes KZ, Grippa WR, D'Agostini NS, Schuab SIPC, Lopes-Júnior LC.   +5 more
europepmc   +1 more source

Inflammation and Atrial Fibrillation: An Exclusive Association or an Accomplice to the Cardiovascular Continuum of Additional Risk Factors? [PDF]

Arq Bras Cardiol
Darrieux F.
europepmc   +1 more source

Unraveling the dual immunomodulatory and immunogenic roles of the central conserved cysteine-rich region in respiratory syncytial virus G protein. [PDF]

Front Microbiol
Gutman J, Paletta AL, Birnberg-Weiss F, Prato CA, Boudgouste A, Goldin CJ, Sastre S, Byrne AB, Pakciarz P, Polack FP, Dvorkin J, Zeida A, Caballero MT, Landoni VI, Fernández GC, Tribulatti MV, Alvarez-Paggi D, Esperante SA.   +17 more
europepmc   +1 more source

[Achievement of pharmacokinetic/pharmacodynamic targets with linezolid therapeutic drug monitoring in critically ill patients]. [PDF]

An Sist Sanit Navar
Irigoyen Rodriguez I, Leache L, Fernández-González J, Egües A, Librero López J.   +4 more
europepmc   +1 more source

[Wells Syndrome: Clinical Presentation and Literature Review]. [PDF]

Rev Med Inst Mex Seguro Soc
Vega-Del Pilar YX, Chew-Bonilla E, Felix-Guerrero LL, Miranda-Contreras NI, Lemini-López A.   +4 more
europepmc   +1 more source

Effects of tocilizumab on renal function and oxidative stress in an experimental model of acute ischemic kidney injury. [PDF]

Rev Esc Enferm USP
Tsuchiya JM, Silva JVG, Alves MG, Silva EO, Maia AO, Vattimo MFF.   +5 more
europepmc   +1 more source

Participación de los eicosanoides en la hipersensibilidad cruzada a anti-inflamatorios no esteroideos: mecanismos y base genética.

Las reacciones de hipersensibilidad cruzada a anti-inflamatorios no esteroideos (RHC-AINEs) son la primera causa de hipersensibilidad a fármacos, siendo la urticaria/angioedema agudos (NIUA) la entidad clínica más frecuente. Se ha aceptado que en las RHC-AINEs existen alteraciones en la vía del ácido araquidónico (AA) debidas a la inhibición de la ...
openaire   +1 more source